-
Development of a Research Registry for Possible Participation in Future Research Studies Conducted Within the IU Center for Alzheimer's ...
The purpose of this Registry is to capture contact and personal health information data for self-referred volunteers and established clinical ...
Exact
Phase N/A
-
Indiana Alzheimer Disease Core Center
The purpose of this program is to identify, evaluate, study, and follow persons who have Alzheimer?s disease, those who ...
Exact
Phase N/A
-
Dominantly Inherited Alzheimer Network (DIAN)
The overall purpose of this research is to understand the changes that occur in dominantly inherited Alzheimer disease.
Exact
Phase N/A
-
Indiana Memory & Aging Study
The purpose of this study is to use brain imaging and genetic biomarkers, cognitive and sensory testing and behavior ratings ...Exact
Phase N/A
-
Post-TBI Irritability and Aggression: Building Evidence-Based Approaches to Management
The purpose of the study is to see if buspirone is effective in treating irritability and aggression in people who ...Exact
Phase N/A
-
A Phase II Study of Cabozantinib (XL184) for Plexiform Neurofibromas in Subjects With Neurofibromatosis Type 1 in Children and Adults
The purpose of this Phase II Study is to determine the response rate of NFI patients with plexiform neurofibromas treated ...
Exact
Phase N/A
-
Neuropsychological Social Emotional and Behavioral Outcomes in Children with Cancer
This research trial studies neuropsychological (learning, remembering or thinking) and behavioral testing in younger patients with cancer. Collecting information over ...
Exact
Phase N/A
-
fMRI of Chemical Sense Stimulation in Substance Use
This study will examine how the human brain reacts to different tastes, and how those brain responses are related to ...
Exact
Phase N/A
-
Phase 2 Study of Imatinib in Children with Neurofibromatosis and Airway Tumors
The purpose of this study is to look at a subset of plexiform neurofibromas and determine if the airway tumors ...
Exact
Phase N/A
-
A Phase 1 Study of Selinexor (KPT-330 IND#125052) a Selective XPO1 Inhibitor in Recurrent and Refractory Pediatric Solid Tumors ...
The investigators will conduct a phase 1 trial of Selinexor in children with recurrent or refractory solid tumors, including CNS ...
Exact
Phase N/A
Showing - of studies